Related Experiment Video
Updated: Jan 30, 2026

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma
Leandro J Chaves1, Bradley Huth2, James J Augsburger3
1Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Abstract:
The management of patients with diffuse invasive conjunctival melanoma focuses on local tumor control and screening for metastasis. Despite the lack of consensus on the benefit of sentinel lymph node biopsy for these neoplasms, the information obtained by histopathology is useful for tumor staging and treatment planning. Due to the lack of evidence of survival improvement, orbital exenteration is being performed with diminishing frequency. We describe a patient with diffuse invasive conjunctival melanoma and lymph node involvement treated by tumor debulking, brachytherapy (custom unshielded radioactive device), and adjuvant ipilimumab who has had a favorable outcome without emergence of local tumor relapse or distant metastasis during 16 months of follow up.
Insights
This study presents a favorable outcome for a patient with invasive conjunctival melanoma and lymph node involvement. Treatment involved debulking, brachytherapy, and ipilimumab, showing no relapse or metastasis after 16 months.
Area of Science:
- Ophthalmology
- Oncology
Background:
- Diffuse invasive conjunctival melanoma management prioritizes local control and metastasis screening.
- Sentinel lymph node biopsy lacks consensus but aids staging.
- Orbital exenteration is decreasing due to limited survival benefit evidence.
Purpose of the Study:
- To report a case of conjunctival melanoma with lymph node involvement.
- To describe a multimodal treatment approach and its outcome.
Main Methods:
- Tumor debulking surgery.
- Brachytherapy using a custom unshielded radioactive device.
- Adjuvant ipilimumab therapy.
Main Results:
- Favorable outcome in a patient with conjunctival melanoma and lymph node metastasis.
- No local tumor relapse observed during 16 months of follow-up.
- No distant metastasis detected during 16 months of follow-up.
Conclusions:
- Multimodal treatment including debulking, brachytherapy, and ipilimumab can be effective for invasive conjunctival melanoma with lymph node involvement.
- This approach may offer a favorable prognosis without local recurrence or distant spread.
Related Concept Videos
Spare Receptors
Diffusion
Diffusion
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Protein Diffusion in the Membrane

